28 July 2025

Six things we learned about health innovation at Imperial Collider 2025

13 July 2025

DNA’s hidden shape reveals target to reverse ovarian cancer chemoresistance

07 May 2025

New flexible hepatitis C treatment options could help elimination efforts

16 December 2024

UK Researchers Awarded £6.4M Grant to Study Protein Dynamics and Cell Health

04 December 2024

Imperial spinout Siftr Bio aims to improve precision of ADC cancer drugs

07 November 2024

Exploring Molecular Glues: Insights from the Sir Geoffrey Wilkinson Lecture

19 September 2024

Institute for Molecular Science and Engineering (IMSE) Research Showcase 2024

01 August 2024

New tool could transform study of cells and help find new drug targets

08 July 2024

Imperial and Crick cancer drug spinout raises £90m to begin clinical development

13 June 2024

Mathematics PhD student wins major science communication competition

01 April 2024

New synthesis platform allows for rapid cancer drug synthesis and testing

26 March 2024

Eight things we learned about commercialising medical research at AYCI 2024

07 March 2024

Impact of artificial intelligence on AMR: Common themes and challenges

11 January 2024

New class of cancer and immunology drug targets mapped with new tagging system

27 November 2023

Unraveling the Secrets of Zombie cells

16 November 2023

UK approves world-first gene-editing treatment for blood disorders

31 October 2023

New £28m Centre to forge the next generation of AI digital healthcare innovators

20 October 2023

Towards using quantum computing to speed up drug development

19 October 2023

New mechanism found that maintains water balance within cells

13 October 2023

Imperial President - College making big moves to accelerate medical innovation

06 September 2023

Apollo Therapeutics raises $226.5m to develop medicines based on uni research

21 August 2023

Nobel-winning bodily ‘pressure sensors’ filmed for first time at Imperial

20 July 2023

New database of drug targets will help fight incurable diseases

23 May 2023

Imperial and Agilent renew partnership for flagship analytical science facility